Lifestyle changes
Build regular activity into your week, avoid smoking, and protect consistent sleep. Keep track of blood pressure and follow the care plan agreed for your personal risk factors.
Heart Health
Heart health supports the circulation that supplies working tissues with oxygen and nutrients throughout the day. It involves the heart muscle itself, the blood vessels it pumps through, and factors such as blood pressure and cholesterol balance. Looking at these areas together gives a fuller picture of long-term cardiovascular wellbeing. Nutritional support can play several different roles within that picture. Some ingredients contribute to the heart’s normal energy and muscle processes, while others are used within an approach to lipid balance or vascular function. The most relevant choice depends on the part of your cardiovascular health you are focusing on and how it fits your existing care. Many useful changes are followed through measurements rather than a noticeable daily sensation. Keeping a clear priority helps make those measurements meaningful and gives each part of your routine a purpose. The wider aim is consistent support for the heart and circulation through the different demands of everyday life.
Warnings
- Check medicine interactions: Ask a pharmacist or clinician to review your exact products alongside your medicines. The ingredient, amount, and treatment determine which combinations are suitable.
- Check potassium suitability: Potassium supplements can be unsafe with kidney disease or medicines that raise blood potassium. Do not add them simply for cramps, energy, or circulation without checking whether they are appropriate.
- Niacin flushing and high doses: Niacin can cause flushing, and high doses can have more serious adverse effects. Do not use the sensation as a measure of effectiveness or take high-dose niacin to manage cholesterol without clinical guidance.
- Tell your surgical team: Share a complete supplement list before a procedure. The team can advise which products to stop and when; a single stopping interval is not appropriate for every supplement or procedure.
Ingredient overview
Goal guidance
Diet changes
Favor vegetables, fruit, whole grains, legumes, and unsaturated fats. Adjust sodium and saturated-fat intake according to your needs and the guidance in your cardiovascular plan.
Who this is for
Adults taking a practical approach to long-term heart health or adding nutritional support to an established cardiovascular care plan.
Who should be careful
Check supplements with anticoagulants, blood-pressure medicines, or other cardiovascular treatments. Kidney disease changes mineral suitability; new chest discomfort, fainting, or significant breathlessness needs prompt medical assessment.
Expected timeline
Follow changes in blood pressure or cholesterol with the appropriate measurements and review schedule. Daily habits contribute over time, even when you do not notice an immediate difference.
Common mistakes
Judging heart health only by how you feel can miss useful information. Keep track of relevant measurements and review supplement combinations alongside your existing care plan.
Ingredients
Coenzyme Q-10 Other Nutrients
Impact
Highest effect
Typical dose100–400 mg / day
CoQ10 is a critical component of the mitochondrial electron transport chain, directly involved in producing ATP, the body's energy currency. Statin drugs can deplete CoQ10 levels, making supplementation important for mitigating side effects and supporting cardiac energy.
- Focuses on
- Most relevant for
- Most relevant for individuals managing heart failure or those taking statin medications who require support for cardiac energy and vascular health.
Potential benefits
- Support for Heart Failure.Pooled clinical data indicates that CoQ10 may help reduce mortality risk and improve exercise capacity in patients with established heart failure.
- Vascular Function Support.Supplementation is associated with improved flow-mediated dilation, which supports the ability of blood vessels to widen and maintain healthy circulation.
- Cholesterol Metabolism.Evidence suggests CoQ10 can modestly lower total and LDL cholesterol while supporting protective HDL levels in adults with metabolic concerns.
Limitations
- Mixed Blood Pressure Results.While it may help lower systolic blood pressure, effects on diastolic pressure are less consistent and it may not affect primary hypertension.
- Uncertain Preventative Benefit.Improvements in risk markers like cholesterol or vessel function have not been definitively proven to prevent heart attacks or strokes in healthy populations.
- Variable Cardiac Pumping.Research shows conflicting results regarding the ability of CoQ10 to significantly improve the heart's actual pumping strength or ejection fraction.
Things to consider
Statin medications are known to significantly deplete natural CoQ10 levels. While supplementation is often used as adjunctive therapy, it should be managed alongside standard clinical care for heart conditions.
Study evidence
114 studiesCoenzyme Q-10 may support some heart-health outcomes, especially as an addition to treatment for heart failure or cardiometabolic disease. Benefits vary across studies, and improvements in blood pressure, cholesterol or blood-vessel function do not establish general prevention of heart attacks or strokes.
EPA (Eicosapentaenoic Acid) Fatty Acids
Impact
Highest effect
Typical dose500–2000 mg / day
As a primary component of Omega-3, EPA directly competes with pro-inflammatory arachidonic acid, reducing the production of inflammatory eicosanoids. This reduction in systemic inflammation is crucial for preventing the progression of atherosclerosis.
- Focuses on
- Most relevant for
- Individuals with high cardiovascular risk or established heart disease and elevated triglycerides, especially those already taking statins.
Potential benefits
- Triglyceride Lowering.EPA is highly effective at reducing high triglyceride levels, a primary marker for cardiovascular risk, particularly when used in concentrated doses.
- Major Coronary Event Reduction.Large-scale clinical trials demonstrate that purified EPA can reduce the risk of heart attack, unstable angina, and the need for coronary revascularization in high-risk patients.
- Improved Vascular Health.EPA may support blood vessel health by improving flow-mediated dilation and endothelial function, helping vessels respond better to changes in blood flow.
Limitations
- Formulation Dependence.The strongest cardiovascular benefits are associated with high-dose prescription-grade purified EPA rather than standard mixed-omega-3 fish oil supplements.
- Inconsistent Blood Pressure Effects.Unlike DHA, EPA has shown minimal to no significant effect on reducing blood pressure or slowing resting heart rate in several clinical studies.
- Uncertain Mortality Impact.While EPA effectively reduces non-fatal coronary events, its impact on stroke prevention and all-cause mortality remains inconsistent across major meta-analyses.
Things to consider
Supplementation with high-dose EPA has been associated with an increased risk of atrial fibrillation or flutter requiring hospitalization and a potential increase in serious bleeding events.
Study evidence
119 studiesPrescription purified EPA lowers triglycerides and can reduce cardiovascular events in selected high-risk people already taking statins. This evidence does not establish the same protection from ordinary EPA supplements, and treatment has been associated with more hospitalizations for atrial fibrillation or flutter.
Magnesium Minerals
Impact
Highest effect
Typical dose200–400 mg / day
Magnesium acts as a natural calcium channel blocker, which helps relax blood vessels and lower blood pressure. It is also a critical cofactor for hundreds of enzymatic reactions, including those that govern cardiac rhythm and endothelial function. Deficiency is common and linked to increased cardiovascular risk.
- Focuses on
- Most relevant for
- Adults with hypertension or low magnesium intake seeking to improve cardiovascular health markers.
Potential benefits
- Blood Pressure Regulation.Meta-analyses indicate that oral magnesium supplementation can modestly lower both systolic and diastolic blood pressure, with more pronounced effects observed in individuals with existing hypertension.
- Vascular Function Support.Clinical evidence suggests magnesium may improve endothelial function, specifically flow-mediated dilation, which helps blood vessels relax and maintain proper circulation.
- Reduced Heart Disease Risk.Higher dietary magnesium intake and serum levels are associated with a lower risk of coronary heart disease and fatal cardiovascular events in long-term observational studies.
Limitations
- Status-Dependent Efficacy.Benefits are often limited to those with low baseline magnesium levels; individuals with adequate intake or normal blood pressure typically show no significant improvement from supplementation.
- Inconsistent Lipid Effects.While some studies show minor reductions in LDL cholesterol for individuals with type 2 diabetes, most research in healthy populations finds no effect on total cholesterol or triglycerides.
- Primary Prevention Uncertainty.Large cohort studies have shown mixed results regarding the prevention of total stroke or non-fatal heart attacks, suggesting supplementation may not benefit everyone equally.
Things to consider
Patients with chronic kidney disease should use caution, as some forms of magnesium may increase the risk of adverse cardiovascular events in advanced stages. Both excessively high and low serum magnesium levels are linked to increased mortality in heart failure patients.
Study evidence
158 studiesMagnesium may help lower blood pressure in some circumstances, but broader heart-protection benefits from routine supplementation are uncertain. Findings depend on magnesium status and underlying health, and higher intake should not be assumed to provide greater protection.
Vitamin K Vitamins
Impact
Highest effect
Typical dose90–300 mcg / day
The K2 form (specifically MK-7) activates matrix Gla-protein (MGP), the most potent inhibitor of vascular calcification. By ensuring calcium is deposited in bone rather than soft tissues, Vitamin K2 directly contributes to maintaining arterial flexibility and preventing stiffness.
- Focuses on
- Most relevant for
- Postmenopausal women and older adults seeking to support arterial elasticity and proper calcium distribution within the cardiovascular system.
Potential benefits
- Vascular Elasticity Support.Unconfirmed. Clinical studies suggest that Vitamin K2 (MK-7) may help maintain arterial flexibility in postmenopausal women, though this benefit is currently unconfirmed for the general population due to mixed trial results in other groups.
- Calcium Management in Arteries.Unconfirmed. Vitamin K helps activate proteins that inhibit calcium buildup in vessel walls; while research indicates it may slow progression in older adults with existing calcification, its effectiveness for general heart disease prevention is not yet proven.
Limitations
- Mixed Results in Chronic Conditions.Clinical trials in individuals with diabetes or chronic kidney disease often show no significant improvement in arterial stiffness or calcification scores after supplementation.
- No Proven Reduction in Major Events.Supplements have not been shown to reduce the risk of clinical events like heart attacks or cardiovascular death, despite their effect on certain vascular biomarkers.
- Limited Evidence for Healthy Adults.Evidence for heart health benefits in healthy younger adults is sparse, with most supportive data coming from observational studies or specific populations with existing deficiencies.
Things to consider
Some research has noted that high-dose Vitamin K1 supplementation may unfavorably increase triglyceride levels in postmenopausal women.
Study evidence
62 studiesVitamin K activates proteins involved in limiting artery calcification, and higher dietary intake is sometimes linked with better heart health. Supplement trials have produced inconsistent vascular benefits, however, and the available evidence does not establish that Vitamin K supplements prevent heart attacks or cardiovascular deaths.
Astaxanthin Other Nutrients
Impact
High effect
Typical dose4–12 mg / day
As a potent lipid-soluble antioxidant, astaxanthin integrates into cell membranes, offering superior protection against peroxidation. It has been shown to reduce markers of inflammation and oxidation, lower triglycerides, and improve circulation by enhancing the flexibility of red blood cells.
- Focuses on
- Most relevant for
- Adults with metabolic risks or dyslipidemia looking to improve blood fat markers and cardiovascular antioxidant status.
Potential benefits
- Blood Lipid Management.Meta-analyses indicate that astaxanthin can significantly increase HDL (good) cholesterol and reduce triglyceride levels, especially in those with pre-existing metabolic concerns.
- Oxidative Stress Reduction.Clinical trials demonstrate that supplementation can lower markers of lipid damage and boost antioxidant enzymes like superoxide dismutase in heart failure and overweight populations.
- Inflammatory Marker Support.At higher doses, research shows potential for reducing specific inflammatory proteins like C-reactive protein (CRP) and TNF-alpha when used for 12 weeks or longer.
Limitations
- Inconsistent LDL Impact.While some trials show benefits, multiple meta-analyses found no significant effect on LDL (bad) cholesterol or total cholesterol levels in the general population.
- Lacks Outcome Data.Current evidence is restricted to laboratory markers and symptoms; it has not been shown to prevent major cardiovascular events like heart attacks or strokes.
- Variable Blood Pressure Effects.Studies on blood pressure reduction have produced mixed results, with significant effects often limited to specific diabetic populations and absent in others.
Things to consider
Impact on inflammatory markers like CRP may require dosages exceeding 12mg daily and consistent use for at least 12 weeks.
Study evidence
16 studiesAstaxanthin may improve some blood fats and markers related to heart health, particularly in people with metabolic conditions, but results vary. The available research does not establish that these changes prevent heart attacks or other major cardiovascular problems.
Citrulline Amino Acids
Impact
High effect
Typical dose2000–6000 mg / day
Unlike Arginine, which is heavily metabolized by the liver, Citrulline bypasses this process and is converted to Arginine in the kidneys, making it a more bioavailable precursor for NO synthesis. This sustained increase in NO improves endothelial function and vasodilation.
- Focuses on
- Most relevant for
- Adults with prehypertension or impaired vascular function, including postmenopausal women and those with type 2 diabetes.
Potential benefits
- Blood Pressure Reduction.Meta-analyses indicate that supplementation can lower both systolic and diastolic blood pressure, with more pronounced effects observed in individuals with elevated baseline levels.
- Improved Vessel Dilation.Regular use may enhance flow-mediated dilation, helping arteries widen more effectively in response to blood flow, particularly in patients with coronary artery disease.
- Cold Stress Attenuation.Evidence suggests citrulline can help mitigate the sharp increases in blood pressure and arterial stiffness typically induced by exposure to cold environments.
Limitations
- Variable Acute Response.Single doses have frequently shown no significant effect on vessel function in healthy young adults, indicating that benefits may depend on longer-term intake.
- Inconsistent Functional Changes.Research on arterial stiffness (pulse wave velocity) remains mixed, with some studies showing no improvement despite reductions in blood pressure.
- Lack of Long-Term Outcome Data.While citrulline improves cardiovascular risk markers, there is currently no evidence that it reduces the actual incidence of heart attacks or strokes.
Things to consider
Observational research has linked higher natural circulating levels of citrulline with increased cardiovascular risk markers, though these findings reflect internal metabolism rather than a direct risk from supplementation.
Study evidence
39 studiesCitrulline may modestly improve blood pressure and blood-vessel function, particularly in people with elevated blood pressure or impaired circulation. Results are inconsistent across settings, and the available research does not establish that supplementation prevents heart attacks, strokes or other cardiovascular events.
Studies
Explore published research for this goal.
Sources
Up to five highest-ranked published examples per ingredient. Study counts and charts include all published studies for the connection.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
- Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
- Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
- Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
- Effects of magnesium supplementation on improving hyperglycemia, hypercholesterolemia, and hypertension in type 2 diabetes: A pooled analysis of 24 randomized controlled trials.
- The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial.
- Positive effects of magnesium supplementation in metabolic syndrome.
- Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
- Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
- Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
- The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
- Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
- Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
- Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis.
- Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia.
- Effects of Astaxanthin Supplementation on Glycemic Control and Lipid Profile in Patients With Prediabetes and Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.
- Impact of astaxanthin on oxidative markers, uric acid, and clinical symptoms in heart failure: a randomized clinical trial.
- Astaxanthin Influence on Health Outcomes of Adults at Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis.
- Effect of oral L-citrulline on brachial and aortic blood pressure defined by resting status: evidence from randomized controlled trials.
- Impact of L-Citrulline Supplementation and HIIT on Lipid Profile, Arterial Stiffness, and Fat Mass in Obese Adolescents with Metabolic-Dysfunction-Associated Fatty Liver Disease: A Randomized Clinical Trial.
- Effects of L-Citrulline Supplementation on Endothelial Function and Blood Pressure in Hypertensive Postmenopausal Women.
- Vascular effects of l-citrulline supplementation in healthy adults are largely influenced by the prehypertensive range of blood pressure: A double-blind, randomized, placebo-controlled, parallel-group study.
- The Assessment of short-term effect of L-Citrulline on endothelial function via FMD to NMD ratio in known CAD patients: A randomized, cross-over clinical trial (Clinical trial number: NCT02638727).
- The Effect of Curcumin Supplementation on Pulse Wave Velocity in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
- The Effects of Nano-curcumin on Metabolic Status in Patients With Diabetes on Hemodialysis, a Randomized, Double Blind, Placebo-controlled Trial.
- Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk.
- Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial.
- The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial.
- Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients.
- Periconception Red Blood Cell Folate and Offspring Congenital Heart Disease : Nested Case-Control and Mendelian Randomization Studies.
- Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies.
- Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.
- The association between folic acid supplementation and congenital heart defects: Systematic review and meta-analysis.
- Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials.
- Effect of Green Tea on Blood Pressure in Healthy Individuals: A Meta-Analysis.
- Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients.
- Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials.
- Effects of green tea on lipid profile in overweight and obese women.
- Taurine ameliorates blood pressure and vascular function in patients with type 2 diabetes: Randomized, double-blind, placebo-controlled trial.
- Seafood diets: hypolipidemic and antiatherogenic effects of taurine and n-3 fatty acids.
- Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study.
- The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials.
- The Effects of Oral Taurine on Resting Blood Pressure in Humans: a Meta-Analysis.
- Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes.
- Vitamin B12 Status and Cardiovascular Risk: Novel Insights from NMR-Based Lipoprotein Profiling in 20,665 Adults.
- Vitamin B12 and folate status in early pregnancy and cardiometabolic risk factors in the offspring at age 5-6 years: findings from the ABCD multi-ethnic birth cohort.
- Orthostatic tolerance in older patients with vitamin B12 deficiency before and after vitamin B12 replacement.
- The impact of folic acid/VB12 deficiency on essential hypertension in children and adolescents: from a nested case-control and a cohort study.
- Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women.
- Intake of folate, vitamin B6 and vitamin B12 and the risk of CHD: the Japan Public Health Center-Based Prospective Study Cohort I.
- The effect of B-vitamins on the prevention and treatment of cardiovascular diseases: a systematic review and meta-analysis.
- Folate and vitamin B(6) intake and risk of acute myocardial infarction in Italy.
- Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial.
- Paricalcitol and endothelial function in chronic kidney disease trial.
- Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
- Does vitamin D supplementation modulate metabolic risk factors of cardiovascular disease? A systematic review and meta-analysis of clinical trials.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.
- Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial.
- The effect of L-carnitine supplementation on lipid profile in adults: an umbrella meta-analysis on interventional meta-analyses.
- The effects of L-carnitine supplementation on cardiovascular risk factors in participants with impaired glucose tolerance and diabetes: a systematic review and dose-response meta-analysis.
- L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes.
- L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I.
- The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.
- The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.
- Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.
- Effect of niacin on endothelial function: a systematic review and meta-analysis of randomized controlled trials.
- Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
- Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
- Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study.
- Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
- Effects of potassium supplementation on office, home, and 24-h blood pressure in patients with essential hypertension.
- Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults.
- A Meta-Analysis of the Impact of Resveratrol Supplementation on Markers of Renal Function and Blood Pressure in Type 2 Diabetic Patients on Hypoglycemic Therapy.
- Resveratrol Improves Heart Function by Moderating Inflammatory Processes in Patients with Systolic Heart Failure.
- Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus.
- Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.
- Selenium concentration is associated with occurrence and diagnosis of three cardiovascular diseases: A systematic review and meta-analysis.
- Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial.
- Exploring the Impact of Selenium Supplementation on Nutritional, Inflammatory, and Cardiac Function in Chronic Heart Failure Patients: A Novel Approach to Managing Deficiency.
- Higher serum selenium concentration is associated with lower risk of all-cause and cardiovascular mortality among individuals with chronic kidney disease: A population-based cohort study of NHANES.
- Correlation between dietary selenium intake and stroke in the National Health and Nutrition Examination Survey 2003-2018.
- Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol.
- Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors.
- Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study.
- Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double-Blind, Multicentre Study.
- Effects of policosanol on postmenopausal women with type II hypercholesterolemia.